Related Experiment Video
Updated: May 21, 2025
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
Targeted nanodelivery systems for personalized cancer therapy
Szymon Roszkowski1, Zofia Durczyńska2, Sylwia Szablewska2
1Division of Biochemistry and Biogerontology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
Summary
Nanotechnology enhances cancer treatment by improving drug delivery to tumors and reducing side effects. Engineered nanocarriers offer targeted therapies, overcoming limitations of conventional chemotherapy.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Conventional cancer therapies like chemotherapy suffer from poor tumor targeting, systemic toxicity, and drug resistance.
- Nanotechnology presents advanced drug delivery systems for preferential tumor accumulation, minimizing off-target effects.
Purpose of the Study:
- To review innovations in engineered nanocarriers for cancer therapy.
- To discuss strategies for optimizing nanocarrier pharmacokinetics, tumor uptake, and overcoming multidrug resistance.
Main Methods:
- Review of passive targeting (exploiting leaky tumor vasculature).
- Review of active targeting (ligand-receptor binding on cancer cells).
- Discussion of multifunctional nanoparticles for combined imaging and therapy.
Main Results:
- Engineered nanocarriers can achieve extended circulation and enhanced tumor localization.
- Multifunctional nanoparticles enable integrated diagnostics and therapeutics with on-demand drug release.
- Nanotherapeutics offer potential to overcome limitations of traditional cancer treatments.
Conclusions:
- Precisely tailored nanotherapeutics leveraging tumor-specific traits can overcome conventional treatment challenges.
- This field promises more effective and personalized nanomedicine for cancer detection and treatment.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:27Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454